30,000 Shares in The Chemours Company $CC Bought by Monaco Asset Management SAM

Monaco Asset Management SAM purchased a new position in shares of The Chemours Company (NYSE:CC) in the third quarter, HoldingsChannel reports. The fund purchased 30,000 shares of the specialty chemicals company’s stock, valued at approximately $475,000.

A number of other hedge funds have also modified their holdings of the company. Baird Financial Group Inc. acquired a new stake in shares of Chemours during the first quarter worth about $148,000. Royal Bank of Canada lifted its stake in Chemours by 6.8% during the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock valued at $7,926,000 after acquiring an additional 37,382 shares during the period. AQR Capital Management LLC acquired a new stake in Chemours during the 1st quarter valued at approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Chemours by 149.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock worth $593,000 after acquiring an additional 25,899 shares during the period. Finally, Empowered Funds LLC purchased a new position in shares of Chemours during the first quarter worth $403,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CC has been the topic of several recent research reports. BMO Capital Markets reaffirmed an “outperform” rating and issued a $20.00 price target on shares of Chemours in a report on Monday, January 19th. UBS Group lowered their target price on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Tuesday, November 11th. JPMorgan Chase & Co. reduced their price target on Chemours from $15.00 to $13.00 and set a “neutral” rating for the company in a research report on Wednesday, December 3rd. Truist Financial boosted their price target on Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, January 21st. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a research note on Wednesday, January 21st. Five research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $16.67.

Trending Headlines about Chemours

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Q4 results showed a modest EPS beat and revenue roughly in line with expectations, demonstrating some underlying demand resilience in parts of the business. The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
• Positive Sentiment: Management highlighted pockets of strength (e.g., data-center cooling / Thermal & Specialized Solutions on the call), which may support parts of near-term revenue even as other segments soften. The Chemours Company (CC) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Full-year revenue guidance was reiterated/updated around $6.0–$6.1B, roughly in line with Street expectations — provides some clarity but little upside surprise. The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: Unusual options activity (notably call buying) suggests some traders are betting on a rebound even as long-only holders trim positions.
• Negative Sentiment: Advanced Performance Materials (APM) showed notable weakness in the quarter, a key reason analysts and traders sold the stock after earnings. Chemours slides 11% on Q4 weakness in advanced performance materials
• Negative Sentiment: Results revealed sharp margin compression, a swing to operating and net losses and negative operating cash flow in some reports — unhelpful for sentiment given Chemours’ leverage and capex needs. Chemours Company (CC) Stock Falls on Q4 2025 Earnings
• Negative Sentiment: Market commentary emphasized that the quarter “missed the vibe” — some outlets flagged EPS was lighter than certain Street models and that investors expected more, which fueled the selloff and heavier-than-normal volume. Why Chemours Plunged Today Chemours Stock Tumbles After Earnings. Data-Center Cooling Couldn’t Save the Quarter.

Chemours Trading Down 16.6%

Shares of CC stock opened at $17.02 on Friday. The Chemours Company has a 1-year low of $9.13 and a 1-year high of $21.85. The company has a market cap of $2.55 billion, a price-to-earnings ratio of -6.86 and a beta of 1.63. The company has a debt-to-equity ratio of 13.66, a current ratio of 1.71 and a quick ratio of 0.88. The stock has a 50 day simple moving average of $15.24 and a 200-day simple moving average of $14.44.

Chemours (NYSE:CC) last issued its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.33 billion. Chemours had a negative net margin of 6.41% and a positive return on equity of 38.34%. The firm’s revenue was down 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.09 EPS. On average, equities research analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a yield of 2.1%. Chemours’s dividend payout ratio (DPR) is currently -14.11%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.